50% off Premium Yearly

NASDAQ:ALXN
Biotech can be a big win or a big loss. A lot of companies have binary outcomes, their product either works or it doesn’t. This company recently had a significant disappointment. US investors are not very sympathetic to these types of situations. They shoot first and ask questions later. If you want to own biotech, he would suggest you own a tech with lots of different products, or buy an ETF that gives you a basket. This one is a broken stock.
Alexion Pharmaceuticals is a American stock, trading under the symbol ALXN (previously ALXN-Q on Stockchase) on the NASDAQ (ALXN). It is usually referred to as NASDAQ:ALXN or ALXN
In the last year, no analyst issued a Buy, Sell, or Hold rating on ALXN (previously ALXN-Q on Stockchase) on Stockchase. Read the latest expert commentary for Alexion Pharmaceuticals.
Alexion Pharmaceuticals was recommended as a Top Pick by Jeff Parent B. Eng. FCSI CIM on 2007-03-09. Read the latest stock experts ratings for Alexion Pharmaceuticals.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for Alexion Pharmaceuticals.
Alexion Pharmaceuticals is covered by Stockchase experts and is worth watching.
On 2021-07-20, Alexion Pharmaceuticals (ALXN) stock closed at a price of $182.90.